228 related articles for article (PubMed ID: 32578135)
1. A systematic review of tumor treating fields therapy for high-grade gliomas.
Shah PP; White T; Khalafallah AM; Romo CG; Price C; Mukherjee D
J Neurooncol; 2020 Jul; 148(3):433-443. PubMed ID: 32578135
[TBL] [Abstract][Full Text] [Related]
2. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
Zhu P; Zhu JJ
Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
[TBL] [Abstract][Full Text] [Related]
3. Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
Mittal S; Klinger NV; Michelhaugh SK; Barger GR; Pannullo SC; Juhász C
J Neurosurg; 2018 Feb; 128(2):414-421. PubMed ID: 28298023
[TBL] [Abstract][Full Text] [Related]
4. Tumor treating fields for high-grade gliomas.
Luo C; Xu S; Dai G; Xiao Z; Chen L; Liu Z
Biomed Pharmacother; 2020 Jul; 127():110193. PubMed ID: 32407989
[TBL] [Abstract][Full Text] [Related]
5. Tumor treating fields in pediatric high-grade glioma.
Green AL; Mulcahy Levy JM; Vibhakar R; Hemenway M; Madden J; Foreman N; Dorris K
Childs Nerv Syst; 2017 Jul; 33(7):1043-1045. PubMed ID: 28470383
[TBL] [Abstract][Full Text] [Related]
6. Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastoma.
Omar AI
J Vis Exp; 2014 Oct; (92):e51638. PubMed ID: 25407354
[TBL] [Abstract][Full Text] [Related]
7. Tumor treating fields therapy is feasible and safe in a 3-year-old patient with diffuse midline glioma H3K27M - a case report.
Gött H; Kiez S; Dohmen H; Kolodziej M; Stein M
Childs Nerv Syst; 2022 Sep; 38(9):1791-1796. PubMed ID: 35181800
[TBL] [Abstract][Full Text] [Related]
8. Application of tumor treating fields for newly diagnosed glioblastoma: understanding of nationwide practice patterns.
McClelland S; Sosanya O; Mitin T; Degnin C; Chen Y; Attia A; Suh JH; Jaboin JJ
J Neurooncol; 2018 Oct; 140(1):155-158. PubMed ID: 29987746
[TBL] [Abstract][Full Text] [Related]
9. The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes.
Rehman AA; Elmore KB; Mattei TA
Neurosurg Focus; 2015 Mar; 38(3):E14. PubMed ID: 25727223
[TBL] [Abstract][Full Text] [Related]
10. Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
Shi W; Blumenthal DT; Oberheim Bush NA; Kebir S; Lukas RV; Muragaki Y; Zhu JJ; Glas M
J Neurooncol; 2020 Jul; 148(3):489-500. PubMed ID: 32535723
[TBL] [Abstract][Full Text] [Related]
11. Alternating Electric Fields Therapy for Malignant Gliomas: From Bench Observation to Clinical Reality.
Wong ET; Lok E; Swanson KD
Prog Neurol Surg; 2018; 32():180-195. PubMed ID: 29990984
[TBL] [Abstract][Full Text] [Related]
12. Tumor Treating Fields in Neuro-Oncological Practice.
Mrugala MM; Ruzevick J; Zlomanczuk P; Lukas RV
Curr Oncol Rep; 2017 Aug; 19(8):53. PubMed ID: 28664468
[TBL] [Abstract][Full Text] [Related]
13. Tumor treating fields for glioblastoma: should it or will it ever be adopted?
Thomas AA; Rauschkolb PK
Curr Opin Neurol; 2019 Dec; 32(6):857-863. PubMed ID: 31609738
[TBL] [Abstract][Full Text] [Related]
14. Tumor Treating Fields: Adjuvant Treatment for High-grade Gliomas.
Anthony P; McArdle S; McHugh M
Semin Oncol Nurs; 2018 Dec; 34(5):454-464. PubMed ID: 30413356
[TBL] [Abstract][Full Text] [Related]
15. Tumour Treating Fields (TTFs) for recurrent and newly diagnosed glioblastoma multiforme.
Mirza FA; Shamim MS
J Pak Med Assoc; 2018 Oct; 68(10):1543-1545. PubMed ID: 30317361
[TBL] [Abstract][Full Text] [Related]
16. Case of glioblastoma patient treated with tumor treating fields therapy at recurrence degenerating to sarcoma.
Majd P; O'Connell DE; Kim RC; Bota DA; Carrillo JA
CNS Oncol; 2017 Apr; 6(2):89-94. PubMed ID: 28303729
[TBL] [Abstract][Full Text] [Related]
17. Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery.
Roux A; Caire F; Guyotat J; Menei P; Metellus P; Pallud J;
Neurochirurgie; 2017 Dec; 63(6):433-443. PubMed ID: 29122306
[TBL] [Abstract][Full Text] [Related]
18. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.
Stupp R; Wong ET; Kanner AA; Steinberg D; Engelhard H; Heidecke V; Kirson ED; Taillibert S; Liebermann F; Dbalý V; Ram Z; Villano JL; Rainov N; Weinberg U; Schiff D; Kunschner L; Raizer J; Honnorat J; Sloan A; Malkin M; Landolfi JC; Payer F; Mehdorn M; Weil RJ; Pannullo SC; Westphal M; Smrcka M; Chin L; Kostron H; Hofer S; Bruce J; Cosgrove R; Paleologous N; Palti Y; Gutin PH
Eur J Cancer; 2012 Sep; 48(14):2192-202. PubMed ID: 22608262
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of tumor-treating fields in recurrent glioblastoma: a systematic review and meta-analysis.
Li X; Jia Z; Yan Y
Acta Neurochir (Wien); 2022 Aug; 164(8):1985-1993. PubMed ID: 35397674
[TBL] [Abstract][Full Text] [Related]
20. Tumor Treating Fields Utilization in a Glioblastoma Patient with a Preexisting Cardiac Pacemaker: The First Reported Case.
McClelland S; Henrikson CA; Ciporen JN; Jaboin JJ; Mitin T
World Neurosurg; 2018 Nov; 119():58-60. PubMed ID: 30064027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
